Pocared Diagnostics

Pocared Diagnostics

Developes the only diagnostic system that automatically detects and identifies infectious diseases, within minutes. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

$10.7m

Early VC

$15.0m

Series F

$3.0m

Series F

$9.5m

Series G

$15.0m

Early VC
*

€22.0m

Debt
Total Funding€48.4m

Recent News about Pocared Diagnostics

Edit
More about Pocared Diagnosticsinfo icon
Edit

Pocared is a pioneering company in the field of infectious disease diagnostics, offering advanced solutions to healthcare providers. The company operates in the medical diagnostics market, focusing on rapid and accurate identification of pathogens in blood, urine, and other body fluids. Pocared's core product is a diagnostic system that provides culture-free testing, delivering results within minutes. This technology aids in optimizing treatment plans and enhancing antibiotic stewardship by preventing overprescribing or misprescribing antimicrobials. The business model revolves around selling its diagnostic systems and related services to clinical laboratories and healthcare facilities. Revenue is generated through the sale of diagnostic equipment, consumables, and maintenance services. Pocared's innovative approach addresses the critical issue of antimicrobial resistance (AMR) and supports evidence-based medical practices.

Keywords: infectious disease, diagnostics, culture-free testing, pathogens, rapid identification, healthcare, clinical labs, antimicrobial resistance, antibiotic stewardship, medical technology.